Tag

Immunomedics

Joydeep Ganguly

Biotech Firm Gilead Plans Expansion in NJ
merger and acquisition

Gilead Sciences to Acquire Immunomedics
research & development

Immunomedics Announces Multiple Clinical and Preclinical Collaborations
fighting cancer

New Jersey’s Strong Foothold in Fighting Cancer
vaccines

Immunomedics Appoints Special Advisor to Its Chairman
cardiovascular

State-Assisted Biopharma Company Immunomedics Focused on Developing Drugs to Fight Aggressive Cancers
Drugs and vitamins

Immunomedics Announces Orphan Drug Designation for Veltuzumab for the Treatment of Immune Thrombocytopenia
lung chancer

Immunomedics Awarded Fast Track Designation by FDA
Health

Immunomedics Prices $30 Million Public Offering of Common Stock
Health

Immunomedics Highlights Clinical Pipeline for Solid Cancer and Lupus Therapy